peptidoglycan acidic potato sprouts | Immunomax lyophilisate for solution for v / m injected 200 IU bottles 3 pcs.

Release form

Lyophilized powder for solution for i / m administration

Packaging

3 vials.

Pharmacological action

Immunomax enhances the immune defense against viral and bacterial infections. The immunopharmacological mechanisms of the drug’s action are that Immunomax activates the following units of the immune system: NK cells, which 2-3 hours after exposure to Immunomax intensely express CD69 activation molecules. Cytolytic activity of NK cells increases by 3 times

circulating monocytes 2-4 hours after activation by Immunomax begin to secrete cytokines: interleukin-8, interleukin-1 beta and tumor necrosis factor alpha

neutrophilic granulocytes are activated by monocytes, a direct effect on neutrophilic granulocytes drug does not render. Interleukin-8 secreted by monocytes causes activation of neutrophilic granulocytes, which is clearly manifested 24 hours after exposure to Immunomax

tissue macrophages, which is manifested in a change in the morphology of these cells, enhancing the production of bactericidal substances, changing the activity of 5'-nucleotidase

the formation of antibodies against foreign antigens, soluble and corpuscular

Immunomax enhances protection against infections caused by viruses (human papillomavirus, herpes simplex virus, parvovirus, carnivore plague virus, etc.) or bacteria (E. coli, salmonella, staphylococcus, chlamydia, mycoplasma, ureaplasma, etc.). This effect of the drug manifests itself in adults and newborns with the introduction of Immunomax in various ways: intramuscularly, intravenously, intraperitoneally, per os.

Indications

for the correction of impaired immunity

for the treatment of pathological conditions (condylomas, warts, dysplasia, etc.) caused by human papilloma virus

, herpes mucosa, mikrojapula, mikrozapula, other bacteria and viruses.

Contraindications

The drug should not be used in individuals with hypersensitivity to Immunomax. Children under 12 years old.

Pregnancy and lactation

No data are available on the effects of Immunomax on pregnant women. As in the case of other drugs, Immunomax should not be used during pregnancy, unless the benefits received by the patient do not exceed the possible risk to the fetus. Immunomax is not recommended for use by nursing mothers.

Dosage and administration

The recommended dose for adults and children 12 years of age and older is 100-200 units intramuscularly, once a day. Before use, the contents of the vial (ampoule) are dissolved in 1 ml of water for injection, injected intramuscularly at 100-200 units, depending on the severity of the disease.

Course of treatment - 6 injections in 1, 2, 3, 8, 9, 10 days of treatment.

For the treatment of recurrent anogenital warts, a course of 6 injections of 200 units of Immunomax is combined with the destruction of warts using one of the generally accepted methods: cryodestruction, electrocoagulation, laser destruction or solcoderm.

For the treatment of infections caused by bacteria or viruses, conduct a course of 6 injections of 100-200 units of Immunomax.

For the correction of weakened immunity, a course of 3-6 injections of 100-200 units of Immunomax is administered.

Storage conditions

Store at a temperature of +4 to +8 degrees. C.

Shelf life

2 years.

Terms and conditions

prescription

lekarstvennaja form

solution for injection

Indications

Urinary tract infections, Chlamydia, HPV, Herpes, Vaginal infections

Immafarma, Russia